Clinical manifestation and molecular genetic characterization of MYH9 disorders

Platelets

Volumn 20, Issue 5, 2009, Pages 289-296

  Provaznikova, Dana ^a   Geierova, Vera ^a   Kumstyrova, Tereza ^b   Kotlin, Roman ^a   Mikulenkova, Dana ^a   Zurkova, Kamila ^a   Matoska, Vaclav ^b   Hrachovinova, Ingrid ^a   Rittich, Simon ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

Giant platelets; HRMA; MYH9; NMMHC IIA; Thrombocytopenia

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN; GLYCOPROTEIN IB ALPHA; MESSENGER RNA; MYOSIN IIA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CATARACT; CELL INCLUSION; CELL SIZE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FECHTNER SYNDROME; FEMALE; GENE; GENE MUTATION; GRANULOCYTE; HEARING IMPAIRMENT; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; MALE; MAY HEGGLIN ANOMALY; MOLECULAR GENETICS; MYH9 GENE; NEPHROTIC SYNDROME; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEBASTIAN SYNDROME; SYNDROME; THROMBOCYTE ANOMALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

BLOOD PLATELETS; DNA MUTATIONAL ANALYSIS; EXONS; FAMILY; GENETIC DISEASES, INBORN; GLYCOPROTEINS; GRANULOCYTES; HUMANS; INCLUSION BODIES; MOLECULAR MOTOR PROTEINS; MUTATION; MYOSIN HEAVY CHAINS; POLYMERASE CHAIN REACTION; SYNDROME; THROMBOCYTOPENIA;

EID: 68649099984     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100902993022     Document Type: Article

References (21)

1. Leal A, Endele S, Stengel C, Huehne K, Loetterle J, Barrantes R, Winterpacht A, Rautenstrauss B. A novel myosin heavy chain gene in human chromosome 19q13.3. Gene 2003;312:165-171. (Pubitemid 37338121)
2. Simons M, Wang M, McBride OW, Kawamoto S, Yamakawa K, Gdula D, Adelstein RS, Weir L. Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes. Circ Res 1991;69:530-539.
3. Toothaker LE, Gonzalez DA, Tung N, Lemons RS, Le Beau MM, Arnaout MA, Clayton LK, Tenen DG. Cellular myosin heavy chain in human leukocytes: Isolation of 50 cDNA clones, characterization of the protein, chromosomal localization and upregulation during myeloid differentiation. Blood 1991;78:1826-1833.
4. Sellers JR. Myosins: A diverse superfamily. Biochim Biophys Acta 2000;1496:3-22.
5. Ahituv N, Sobe T, Robertson NG, Morton CC, Taggart RT, Avraham KB. Genomic structure of the human unconventional myosin VI gene. Gene 2000;261:269-275. (Pubitemid 32146498)
6. Friedman TB, Sellers JR, Avraham KB. Unconventional myosins and the genetics of hearing loss. Am.J Med Genet 1999;89:147-157.
7. Maupin P, Phillips CL, Adelstein RS, Pollard TD. Differential localization of myosin/II isozymes in human cultured cells and blood cells. J Cell Sci 1994;107(part 11):3077-3090. (Pubitemid 24365211)
8. Cai Y, Biais N, Giannone G, Tanase M, Jiang G, Hofman JM, Wiggins CH, Silbezan P, Bugun A, Ladoux B, Sheetz MP. Nonmuscle myosin IIA-dependent force inhibits cell spreading and drives F-actin flow. Biophys J 2006;91:3907-3920. (Pubitemid 44788333)
9. Sandquist JC, Swenson KI, Demali KA, Burridge K, Mean AR. Rho kinase differentially regulates phosphorylation of nonmuscle myosin II isoforms A and B during cell rounding and migration. J Biol Chem 2006;281:35873-35883. (Pubitemid 46041319)
10. Wei Q, Adelstein RS. Conditional expression of a truncated fragment of nonmuscle myosin II-A alters cell shape but not cytokinesis in HeLa cells. Mol Biol Cell 2000;11:3617-3627. (Pubitemid 30781955)
11. Burt RA, Collinge JE, Kile BT. Description of a novel mutation leading to MYH-9-related disease. Thromb Res 2008;122:861-863.
12. Li Y, Friedmann DR, Mhatre AN, Lalwani AK. MYH9-siRNA and MYH9 mutant alleles. Expression in cultured cell lines and their effects upon cell structure and function. Cell Motil Cytoskeleton 2008;65:393-405.
13. Hegglin R. Gleichzeitige konstitutionelle veranderungen an neutrophilen und thrombocyten. Helvetica Medica Acta 1945;12:439-440.
14. May R. Leukozyteneinschlusse. Deutsches Archiv Klinische Medizin 1909;96:1-6.
15. Kunishima S, Matsushita T, Kojima T, Sako M, Kimura F, Jo EK, Inoue C, Kamiya T, Saito H. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: Association of subcellular localization with MYH9 mutations. Lab Invest 2003;83:115-122. (Pubitemid 36126056)
16. Kunishima S, Matsushita T, Hamaguchi M, Saito H. Identification and characterization of the first large deletion of the MYH9 disorders. Eur J Haematol 2008;80:540-544.
17. Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, Savige J, Denison JC, Gregory MC, White JG, Barker DF. et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macro-thrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein and Alport-like syndromes. Am J Hum Genet 2001;69:1033-1045. (Pubitemid 33015818)
18. Pecci A, Panza E, Pujol-Moix N, Klersy C, Di Bari F, Bozzi V, Gresele P, Lethagen S, Fabris F, Dufour C. et al. Position of nonmuscle myosin heavy chain IIA (NMHCIIA) mutations predicts the natural history of MYH9-related disease. Hum Mutat 2008;29:409-417.
19. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS. et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008;40:1175-1184.
20. Kao WHL, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR. et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008;40:1185-1192.
21. Léon C, Eckly A, Hechler B, Aleil B, Freund M, Ravanat C, Jourdain M, Nonne C, Weber J, Tiedt R. et al. Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. Blood 2007;110:3183-3191. (Pubitemid 350106310)